Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-005207-25Phase 3Completed
Phase 3, open-label, single-arm trial of lidocaine in None, sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Plasma peak concentration of lidocaine during DLTB. Started Dec 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-005207-25.